Cancer Gene Therapy Market

• The global cancer gene therapy market is segmented on the basis of type, therapy and end-users
• The global cancer gene therapy market is expected to reach XX USD Mn by 2024 with a growing CAGR of XX% from 2018 to 2024
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies

Request Sample Report: https://bit.ly/2INre91

Cancer gene therapy is a process that treats cancers by inserting therapeutic DNA into the patient. Cancer gene therapy is gaining popularity as a result of its success rate in preclinical and clinical trial stages. The most common technique for cancer gene therapy involves replacing a mutated gene that is causing cancer with a healthy copy of the gene.
Globally, rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. Various factors, such as the increase in the prevalence of cancer, increase in funding from various government and non-government organizations, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment, lack of reimbursement policies for advanced gene therapy methods are restraining the growth of the global market for cancer gene therapy.
The global cancer gene therapy market is divided into following categories-
1. Type
• Gene Induced Immunotherapy
o Tumour Antigen Gene Delivery
o Cytokine Gene Delivery
• Oncolytic Virotherapy
o Adenoviruses
o Adeno Associated Virus
o Lentiviruses
o Alpha Virus
o Retrovirus
o Herpes Simplex Virus
o Vaccinia virus
o Simian Virus
• Gene Transfer/ Gene Replacement
• Electroporation
• Magnetofection
• Naked / Plasmid Vectors
• Gene Gun
• Sonoporation
2. Therapy
• Retroviral Therapy
• Adenoviral Therapy
3. End-users
• Hospitals
• Oncology institutes
• Biotechnological companies
• Clinical Research Labs
And geographically, the cancer gene therapy is segmented into North America, Europe, Latin America, Asia- Pacific and the Middle East and Africa.
North America leads the global cancer gene therapy market owing to the large pool of aging population and advancements in technology high investments in R & D activities along with the government support will boost industry demand.
The U.K. market is anticipated to grow rapidly due to the rising occurrence of cancer along with the increase in acceptance of gene technology.
Asia-Pacific is expected to witness high growth in cancer gene therapy market, due to increase in government initiatives, rising economy, and improvement in healthcare infrastructure in the region.
Some of the major companies operating in the global cancer gene therapy market are Urigen Pharmaceuticals Inc. (U.S), GenVec.Inc (U.S), Oxford BioMedica (U.K), Vical (U.S), ANI Pharmaceuticals, Inc. (U.S), and Genzyme Corporation (U.S). Novartis AG (Switzerland), and Cell Medica (U.K.). Some of the market development include Novartis receiving U.S. FDA Oncologic Drugs Advisory Committee (ODAC) recommended approval of CTL019, in 2017, an investigational chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of relapsed or refractory pediatric and young adult patients with B-cell acute lymphoblastic leukemia.
Major industry participants adopting various strategies to retaining their market positions such as the development of advanced technologies, maintaining a strong intellectual property, strategic collaborations, and joint ventures adopted by in the global cancer gene therapy. The players are constantly engaged in R&D in order to develop novel methods to treat various life-threatening diseases. Increased in the adoption of emerging genomic technologies such as Next Generation Sequencing (NGS) and high-density microarray coupled with favorable government initiatives will fuel global cancer gene therapy market.
Key Questions Answered
• What is the current and future cancer gene therapy market outlook worldwide? What trends are affecting the global market?
• What is the competitive landscape and market share of major players in the cancer gene therapy globally?
• What are the key, high growth markets that cancer gene therapy manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the cancer gene therapy currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of cancer gene therapy?
• What are the challenges and barriers that have hindered widespread adoption of cancer gene therapy?
Reasons to buy cancer gene therapy market Report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

For More Information: https://bit.ly/2N5JYRQ